Elevation Oncology Total Liabilities

Elevation Oncology (ELEV) currently reports a total liabilities of $35M as of March 2025. That compares with $33M in the prior-year period — up 7.1% year over year. Use the charts on this page to explore Elevation Oncology's total liabilities history and peer comparisons.

Elevation Oncology's total liabilities increased from $33M to $35M — a 7.1% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elevation Oncology reported $35M in total liabilities as of March 2025. That compares with $33M in the prior-year period — up 7.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elevation Oncology, and consider following ELEV for alerts when major investors trade the stock.

Elevation Oncology is classified in the Healthcare sector. On total liabilities, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ELEV with unrelated industries.